GSOL (Grayscale Solana Staking ETF Shares) Stock Analysis - News

Grayscale Solana Staking ETF Shares (GSOL) is a publicly traded the market company. As of May 21, 2026, GSOL trades at $6.47 with a market cap of $0 and a P/E ratio of 0.00. GSOL moved +2.14% today. Year to date, GSOL is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces GSOL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in GSOL news today?

Grayscale Rebalances Funds: DeFi Fund Adds 13.59% Ethena, Smart Contract Fund Holds 29.69% Solana: Grayscale rebalanced its DeFi Fund for Q1 2026 by selling Aerodrome Finance and other assets to establish a 13.59% position in Ethena. The Smart Contract Fund now holds Ether at 30.14%, Solana at 29.69%, Cardano at 17.96%, Avalanche at 7.69%, Hedera at 7.41% and Sui at 7.11%.

GSOL Key Metrics

Key financial metrics for GSOL
MetricValue
Price$6.47
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume1.87M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest GSOL News

GSOL Analyst Consensus

GSOL analyst coverage data. Average price target: $0.00.

Common questions about GSOL

What changed in GSOL news today?
Grayscale Rebalances Funds: DeFi Fund Adds 13.59% Ethena, Smart Contract Fund Holds 29.69% Solana: Grayscale rebalanced its DeFi Fund for Q1 2026 by selling Aerodrome Finance and other assets to establish a 13.59% position in Ethena. The Smart Contract Fund now holds Ether at 30.14%, Solana at 29.69%, Cardano at 17.96%, Avalanche at 7.69%, Hedera at 7.41% and Sui at 7.11%.
Does Rallies summarize GSOL news?
Yes. Rallies summarizes GSOL news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is GSOL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GSOL. It does not provide personalized investment advice.
GSOL

GSOL